Described herein are compounds that are useful as protein kinase inhibitors having the formula: ##STR1## where R.sup.1-4, Q, and T are described in the specification. The compounds are useful for treating disease states in mammals that are alleviated by a protein kinase inhibitor, particularly diseases such as cancer, inflammatory disorders, restenosis, and cardiovascular disease.

Hierin beschreven zijn de samenstellingen die als eiwitkinaseinhibitors die de formule hebben nuttig zijn: ## STR1 ## waar r.sup.1-4, Q, en T in de specificatie worden beschreven. De samenstellingen zijn nuttig om ziektestaten in zoogdieren te behandelen die door een eiwitkinaseinhibitor, in het bijzonder ziekten zoals kanker, ontstekingswanorde, restenosis, en cardiovasculaire ziekte worden verminderd.

 
Web www.patentalert.com

< Glucocorticoid receptor antagonists for treatment of diabetes

< Synthetic compounds for treatment of inflammation

> Pyrrole derivatives and cell death inhibitors

> Method of inhibiting pancreatic .beta.-cell p135 O-glycosylation

~ 00078